No Matches Found
No Matches Found
No Matches Found
Rajnish Wellness Ltd
Rajnish Wellness Ltd is Rated Strong Sell
Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Rajnish Wellness Ltd Stock Falls to 52-Week Low of Rs.0.39
Rajnish Wellness Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.0.39, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance issues.
Rajnish Wellness Ltd Stock Falls to 52-Week Low of Rs.0.39
Rajnish Wellness Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.0.39 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance issues.
Rajnish Wellness Ltd is Rated Strong Sell
Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 January 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Are Rajnish Wellness Ltd latest results good or bad?
Rajnish Wellness Ltd's latest results show strong revenue growth of 93.67% quarter-on-quarter, but the company incurred a net loss of ₹0.91 crores, indicating significant operational challenges and a critical profitability crisis despite the topline increase.
Rajnish Wellness Q3 FY26: Losses Deepen as Revenue Surge Fails to Translate into Profitability
Rajnish Wellness Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹49.75 crores, reported a net loss of ₹0.91 crores in Q3 FY26 (October-December 2025), marking a dramatic reversal from the modest profit of ₹0.06 crores posted in the previous quarter. The loss represents a concerning deterioration in profitability despite a robust 93.67% quarter-on-quarter revenue surge to ₹23.24 crores.
Are Rajnish Wellness Ltd latest results good or bad?
Rajnish Wellness Ltd's latest results are concerning, showing a 31.11% year-on-year decline in net sales and a negative operating profit margin of -1.92%, indicating significant operational challenges and profitability issues. The company needs a strategic reassessment to address ongoing demand weakness and market share erosion.
When is the next results date for Rajnish Wellness Ltd?
The next results date for Rajnish Wellness Ltd is 07 February 2026.
Rajnish Wellness Ltd is Rated Strong Sell
Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 15 January 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 04 February 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.
Rajnish Wellness Ltd Stock Hits 52-Week Low Amidst Continued Decline
Rajnish Wellness Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new 52-week low of Rs.0.43 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific factors.
Rajnish Wellness Ltd Stock Hits 52-Week Low Amidst Continued Downtrend
Rajnish Wellness Ltd, a company operating within the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.0.43, marking a significant decline in its stock price amid a challenging market environment.
Rajnish Wellness Ltd is Rated Strong Sell
Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Jan 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 22 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.
Rajnish Wellness Ltd is Rated Strong Sell
Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Jan 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 07 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Rajnish Wellness Ltd Stock Hits 52-Week Low Amidst Continued Decline
Rajnish Wellness Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week and all-time low of Rs.0.44 today, marking a significant decline amid a challenging market environment and company-specific headwinds.
Rajnish Wellness Ltd Stock Hits 52-Week Low Amidst Continued Downtrend
Rajnish Wellness Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week and all-time low of Rs.0.48 today, marking a significant downturn in its stock performance amid a series of declines over the past week.
Rajnish Wellness Ltd is Rated Strong Sell
Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 January 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company’s performance and outlook.
Rajnish Wellness Stock Falls to 52-Week Low of Rs.0.58 Amidst Continued Downtrend
Rajnish Wellness, a company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.0.58 today, marking a significant decline amid a sustained downward trend over recent sessions.
Rajnish Wellness Stock Falls to 52-Week Low of Rs.0.59
Rajnish Wellness, a company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low price of Rs.0.59, marking a significant decline in its stock performance amid broader market fluctuations.
Rajnish Wellness Stock Falls to 52-Week Low of Rs.0.61
Rajnish Wellness, a company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low price of Rs.0.61, marking a significant decline in its stock value amid a broader market environment where benchmark indices continue to show strength.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
